Aldafermin quantitatively improves inflammation in a 24-week clinical trial in patients with nonalcoholic steatohepatitis
Explore this paper's citation graph
- Type
- article
- Published
- 2022-07-01
- Cited by
- 0
- References
- 0
- OpenAlex
- https://openalex.org/W4283818330
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:250292299
Keywords
Nonalcoholic steatohepatitis, Medicine, Inflammation, Internal medicine, Steatohepatitis
References
No references recorded for this paper.
Cited by
No citing papers recorded for this paper.
Related papers
- Correction of endotoxemia in patients with nonalcoholic steatohepatitis
- Exploring factors related to clinically advanced fibrosis in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis
- Sa1567 MRI INTENSITY PATTERNS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND ALCOHOLIC STEATOHEPATITIS
- Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis.
- Role of Lipid Profile in the Assessment of Nonalcoholic Steatohepatitis in Prediabetic and Diabetic Patients with Nonalcoholic Fatty Liver Disease